Kyntra Bio, Inc. (KYNB) — Cash Flow Quality Index
Kyntra Bio, Inc. (KYNB) has a Cash Flow Quality Index of -0.33x as of June 2026. Operating cash flow of $-3.99 Million is below net income of $11.97 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Kyntra Bio, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kyntra Bio, Inc. Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Kyntra Bio, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See how leveraged is Kyntra Bio, Inc.'s balance sheet to measure how much of total assets are equity-financed.
Annual Cash Flow Quality Index for Kyntra Bio, Inc. (2025–2025)
Year-by-year earnings quality comparison for Kyntra Bio, Inc.. For the full cash flow conversion analysis, see KYNB cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.03x | $-4.77 Million | $183.45 Million | — |